FDA NDC Directory · JSON-LD · Markdown

Cholestyramine for Oral Suspension

NDC 62135-937 · HUMAN PRESCRIPTION DRUG · POWDER

Labeler / ManufacturerChartwell RX, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA074562
Dosage form / routePOWDER · ORAL
Active ingredientsCHOLESTYRAMINE (4 g/5.7g)
Marketing started19960815
Package count1

External sources

Source: openFDA. Public-domain (CC0).